Mepolizumab for eosinophilic chronic obstructive pulmonary disease (New England journal of medicine, 2017)

(untitled) - Pavord, I; Chanez, P; Criner, G; Kerstjens, H; Korn, S; Lugogo, N; Martinot, J; Sagara, H; Albers, F; Bradford, E; Harris, S; Mayer, B; et al.